GURUFOCUS.COM » STOCK LIST » Industrials » Construction » ChromoGenics AB (OSTO:CHRO) » Definitions » Debt-to-Asset

ChromoGenics AB (OSTO:CHRO) Debt-to-Asset : 0.50 (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is ChromoGenics AB Debt-to-Asset?

ChromoGenics AB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was kr0.00 Mil. ChromoGenics AB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was kr67.72 Mil. ChromoGenics AB's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2024 was kr136.13 Mil. ChromoGenics AB's debt to asset for the quarter that ended in Mar. 2024 was 0.50.


ChromoGenics AB Debt-to-Asset Historical Data

The historical data trend for ChromoGenics AB's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ChromoGenics AB Debt-to-Asset Chart

ChromoGenics AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only 1.06 0.36 0.27 0.39 0.40

ChromoGenics AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.40 0.42 0.47 0.43 0.50

Competitive Comparison of ChromoGenics AB's Debt-to-Asset

For the Building Products & Equipment subindustry, ChromoGenics AB's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ChromoGenics AB's Debt-to-Asset Distribution in the Construction Industry

For the Construction industry and Industrials sector, ChromoGenics AB's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where ChromoGenics AB's Debt-to-Asset falls into.



ChromoGenics AB Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

ChromoGenics AB's Debt-to-Asset for the fiscal year that ended in Dec. 2022 is calculated as

ChromoGenics AB's Debt-to-Asset for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ChromoGenics AB  (OSTO:CHRO) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


ChromoGenics AB Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of ChromoGenics AB's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


ChromoGenics AB (OSTO:CHRO) Business Description

Traded in Other Exchanges
Address
Ullforsgatan 15, Uppsala, SWE, 752 28
ChromoGenics AB develops and produces dynamic glass with controllable optical properties in Sweden and internationally. The company offers ConverLight, an electrochromic glass, which provides UV protection for use in single glass pane and insulating glass unit solutions. This glass is suitable for new construction, reconstruction, and renovation and offers ultraviolet protection that reduces the risk of fading interiors.

ChromoGenics AB (OSTO:CHRO) Headlines